MH
Michael A Henos
Director

Michael A Henos insider trades: Glycomimetics (GLYC) stock buys and sales

Director, Glycomimetics Last trade Dec 22, 2014 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2007
5
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 22, 2014GLYC↓ Sell$181K
Dec 17, 2014GLYC↓ Sell$60K
Jun 13, 2014GLYC↑ Buy$70K
Mar 16, 2010GXDX↓ Sell$177K
Jul 1, 2009GXDX↓ Sell$237K
Oct 31, 2008AGIXQ.PK↓ Sell$6K
Aug 14, 2008GXDX↓ Sell$22.9M
Mar 10, 2008GXDX↓ Sell$1.7M
Mar 5, 2008GXDX↓ Sell$10.1M
Dec 6, 2007AGIX↓ Sell$15K
Nov 2, 2007GXDX↓ Sell$4.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael A Henos's insider trades

Michael A Henos is a director at Glycomimetics (GLYC). Since Nov 2, 2007, Michael has reported 1 open-market purchase worth $70K and 10 sales worth $39.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (19 filings), option exercises (5 filings), conversions (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GLYC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.